<table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 5 Effects on steady-state fexofenadine pharmacokinetics after 7 days of co-administration with fexofenadine hydrochloride 120 mg every 12 hours in healthy adult subjects (n=24)</caption>
<col></col>
<col></col>
<col></col>
<thead>
<tr>
<th valign="top">
<content stylecode="italics">Concomitant Drug </content>
</th>
<th align="center" valign="top">
<content stylecode="italics">C<sub>maxSS</sub>
<br/>(Peak plasma concentration)</content>
</th>
<th align="center" valign="top">
<content stylecode="italics">AUCss<sub>(0-12h)</sub>
<br/>(Extent of systemic exposure)</content>
</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top"> Erythromycin <br/> (500 mg every 8 hrs)</td>
<td align="center" valign="top"> +82%</td>
<td align="center" valign="top"> +109%</td>
</tr>
<tr>
<td valign="top"> Ketoconazole <br/> (400 mg once daily)</td>
<td align="center" valign="top"> +135%</td>
<td align="center" valign="top"> +164%</td>
</tr>
</tbody>
</table>